Cargando…
Association of metformin use with Alzheimer’s disease in patients with newly diagnosed type 2 diabetes: a population-based nested case–control study
Metformin reduces insulin resistance, which constitutes a pathophysiological connection of diabetes with Alzheimer’s disease (AD), but the evidence of metformin on AD development was still insufficient and conflicting. We investigated AD risk in patients with newly diagnosed type 2 DM treated with m...
Autores principales: | Ha, Junghee, Choi, Dong-Woo, Kim, Kwang Joon, Cho, So Yeon, Kim, Hyunjeong, Kim, Keun You, Koh, Youngseung, Nam, Chung Mo, Kim, Eosu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674300/ https://www.ncbi.nlm.nih.gov/pubmed/34912022 http://dx.doi.org/10.1038/s41598-021-03406-5 |
Ejemplares similares
-
Pioglitazone use associated with reduced risk of the first attack of ischemic stroke in patients with newly onset type 2 diabetes: a nationwide nested case–control study
por: Ha, Junghee, et al.
Publicado: (2021) -
Plasma adiponectin levels predict cognitive decline and cortical thinning in mild cognitive impairment with beta-amyloid pathology
por: Kim, Keun You, et al.
Publicado: (2022) -
Restless leg syndrome and risk of all-cause dementia: a nationwide retrospective cohort study
por: Kim, Keun You, et al.
Publicado: (2023) -
Long-Term Culture of Organotypic Hippocampal Slice from Old 3xTg-AD Mouse: An ex vivo Model of Alzheimer’s Disease
por: Jang, Sooah, et al.
Publicado: (2018) -
A troubled mind troubles the kidney: a brain-to-kidney axis?
por: Kim, Keun You, et al.
Publicado: (2022)